ImmunoCellular Therapeutics

ImmunoCellular Therapeutics ( IMUC) is a development-stage company which is seeking to develop and commercialize new therapeutics to fight cancer using the immune system. This stock is trading up 7.8% to $2.34 in recent trading.

Today's Range: $2.24-$2.39

52-Week Range: $1.51-$4.00

Volume: 1.07 million

Three-Month Average Volume: 435,416

From a technical perspective, IMUC is ripping higher here right above its 50-day moving average of $2.05 with monster upside volume. This move has started to push shares of IMUC into breakout territory, since the stock has taken out some near-term overhead resistance levels at $2.27 to $2.28. Shares of IMUC are now quickly moving within range of another near-term breakout trade. That trade will hit if IMUC manages to take out its 200-day moving average of $2.65 with high volume.

Traders should now look for long-biased trades in IMUC as long as it's trending above $2.27 to $2.28, and then once it sustains a move or close above its 200-day at $2.65 with volume that hits near or above 435,416 shares. If that breakout hits soon, then IMUC will set up to re-test or possibly take out its next major overhead resistance levels $2.93 to $2.94. Any high-volume move above those levels will then put $3.26 to $3.50 into range for shares of IMUC.

Rosetta Genomics

Rosetta Genomics ( ROSG) develops diagnostic tests and therapeutic tools. Its product portfolio comprises of tests such as miRview mets2 / mets, miRview squamous, miRview meso and miRview kidney. This stock is trading up 2% to $4.63 in recent trading.

Today's Range: $4.65-$4.76

52-Week Range: $1.40-$23.43

Volume: 136,000

Three-Month Average Volume: 553,442

From a technical perspective, ROSG is moving modestly higher here back above its 50-day moving average of $4.61 with lighter-than-average volume. This move is quickly pushing shares of ROSG within range of triggering a near-term breakout trade. That trade will hit if ROSG manages to take out some near-term overhead resistance levels at $4.95 to $5 with high volume.

Traders should now look for long-biased trades in ROSG as long as it's trending above its 50-day at $4.61, and then once it sustains a move or close above those breakout levels with volume that hits near or above 553,442 shares. If that breakout triggers soon, then ROSG will set up to re-test or possibly take out its next major overhead resistance levels at $5.50 to $5.98. Any high-volume move above $5.98 will then put $6.27 to $7 into range for shares of ROSG.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.

If you liked this article you might like

Rosetta Genomics (ROSG) Stock Closed Up on Cantor Fitzgerald Rating

4 Biotech Stocks Under $10 Poised for Big Breakouts

Rosseta Genomics (ROSG) Stock Continues To Climb Today on Analyst Upgrade

Rosetta Genomics (ROSG) Stock is Spiking on Receipt of Cancer Origin Test Patent

Rosetta Genomics (ROSG) Stock Sells Off Today Following Tuesday's Surge